Registration Dossier

Administrative data

Description of key information

No carcinogenicity studies are available for PERKALINK 900. However, the substance did not show mutagenic effects in in vivo genotoxicity tests and there is no indication for preneoplastic lesions in repeated dose toxicity studies with up to subchronic exposure. Thus, a carcinogenic potential of PERKALINK 900 can be considered as unlikely.

Key value for chemical safety assessment

Justification for classification or non-classification

Additional information

No carcinogenicity studies are available for PERKALINK 900. However, the substance did not show mutagenic effects in in vivo genotoxicity tests and there is no indication for preneoplastic lesions in repeated dose toxicity studies with up to subchronic exposure. Thus, a carcinogenic potential of PERKALINK 900 can be considered as unlikely.